BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18838707)

  • 41. Proximal-type epithelioid sarcoma of the uterine corpus.
    Venizelos I; Anagnostou E; Papathomas TG; Arsos G; Mentzel T
    Histopathology; 2011 Jan; 58(2):321-3. PubMed ID: 21255067
    [No Abstract]   [Full Text] [Related]  

  • 42. [Choriocarcinoma in extrauterine tubal pregnancy].
    Horn LC; Bilek K; Pretzsch G; Baier D
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):375-7. PubMed ID: 8088495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Documentation of complete resolution of gestational choriocarcinoma in the oophorectomized patient.
    O'Hanlan KA; Wu TF; Teng NN
    Gynecol Oncol; 1993 Nov; 51(2):261-5. PubMed ID: 8276305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Choriocarcinoma of the uterine cervix].
    Lampe D; Methfessel HD
    Zentralbl Gynakol; 1988; 110(15):960-3. PubMed ID: 2847445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Obstet Gynecol; 1982 Sep; 60(3):354-60. PubMed ID: 6289207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chorioepithelioma. Report of 2 cases].
    Kofler E; Leodolter S; Ulm R
    Wien Med Wochenschr; 1975 Jul; 125(28-31):444-6. PubMed ID: 1241196
    [No Abstract]   [Full Text] [Related]  

  • 47. [Roles of ras genes on biological properties of human choriocarcinoma cells].
    Watari H
    Hokkaido Igaku Zasshi; 1995 Jul; 70(4):623-34. PubMed ID: 7590607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
    Cui JQ; Shi YF; Zhou HJ; Li JQ
    Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support: a case report.
    Knox S; Brooks SE; Wong-You-Cheong J; Ioffe O; Meisenberg B; Goldstein DP
    Gynecol Oncol; 2002 Apr; 85(1):204-8. PubMed ID: 11925147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis.
    Cole LA; Khanlian SA; Riley JM; Butler SA
    J Reprod Med; 2006 Nov; 51(11):919-29. PubMed ID: 17165440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recurrences of placental choriocarcinoma].
    Ben Ayed F; Bellet D; Badri N; Spielmann M; Droz JP; Tursz T; Amiel JL
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(3):383-4. PubMed ID: 6889617
    [No Abstract]   [Full Text] [Related]  

  • 52. [A case with non-gestational choriocarcinoma of the uterus].
    Isonishi S; Yasuda M; Yoshioka M; Nakabayashi Y; Sinozuka M; Ohtaka T; Terashima Y; Hachiya S
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr; 37(4):669-72. PubMed ID: 4039345
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recent advances in the treatment of choriocarcinoma].
    Tomoda Y; Ishizuka T; Gotoh S; Furuhashi Y; Inoue T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1833-9. PubMed ID: 3289501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pathology of choriocarcinoma.
    Ober WB; Edgcomb JH; Price EB
    Ann N Y Acad Sci; 1971 Jan; 172(10):299-426. PubMed ID: 4333065
    [No Abstract]   [Full Text] [Related]  

  • 56. Relationship between plasma levels of human chorionic gonadotropin and tumor growth during chemotherapy for human choriocarcinoma maintained in the hamster cheek pouch.
    Knecht M; Hertz R
    Cancer Treat Rep; 1978 Dec; 62(12):2101-3. PubMed ID: 571763
    [No Abstract]   [Full Text] [Related]  

  • 57. [Factors affecting late treatment results with uterine choriocarcinoma patients].
    Mokshin VE
    Vopr Onkol; 1985; 31(7):62-8. PubMed ID: 4024562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.
    Feng H; Cheung AN; Xue WC; Wang Y; Wang X; Fu S; Wang Q; Ngan HY; Tsao SW
    Gynecol Oncol; 2004 Aug; 94(2):375-82. PubMed ID: 15297175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of primary therapy refractory choriocarcinoma using the EMA-CO protocol].
    Fechtig A; de Dycker RP; Schumacher T; Zajaczkowski T; Neumann RL
    Geburtshilfe Frauenheilkd; 1992 Apr; 52(4):235-8. PubMed ID: 1607119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Possible influence of granulocyte colony-stimulating factor and recombinant human erythropoietin on human chorionic gonadotropin secretion during chemotherapy for choriocarcinoma.
    Lösch A; Lahodny J; Petru E
    Gynecol Oncol; 2001 Oct; 83(1):165-6. PubMed ID: 11585432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.